Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the safety and tolerability of multiple doses of VAK694 as well as
change in symptoms and biomarkers in patients with seasonal allergic rhinitis